Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
6 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Pancreas as an Unusual Metastatic Site of Medullary Thyroid Carcinoma: A Case of Very Long-term Follow-up Under Prolonged Treatment with Somatostatin Analogues.
Endocr Metab Immune Disord Drug Targets. 2024 Jan 26. doi: 10.2174/0118715303277049231229051823. Online ahead of print.
Endocr Metab Immune Disord Drug Targets. 2024.
PMID: 38284724
Radiomics to predict immunotherapy efficacy in advanced renal cell carcinoma: A retrospective study.
Rossi E, Boldrini L, Maratta MG, Gatta R, Votta C, Tortora G, Schinzari G.
Rossi E, et al. Among authors: maratta mg.
Hum Vaccin Immunother. 2023 Dec 31;19(1):2172926. doi: 10.1080/21645515.2023.2172926. Epub 2023 Feb 1.
Hum Vaccin Immunother. 2023.
PMID: 36723981
Free PMC article.
Item in Clipboard
Primary versus secondary antiemetic prophylaxis with NK1 receptor antagonists in patients affected by gastrointestinal malignancies and treated with a doublet or triplet combination regimen including oxaliplatin and/or irinotecan plus fluoropyrimidines: A propensity score matched analysis.
Parisi A, Giampieri R, Mammarella A, Felicetti C, Salvatore L, Bensi M, Maratta MG, Strippoli A, Filippi R, Satolli MA, Petrillo A, Daniele B, De Tursi M, Di Marino P, Giordano G, Landriscina M, Vitale P, Zurlo IV, Dell'Aquila E, Tomao S, Depetris I, Di Pietro FR, Zoratto F, Ciardiello D, Pensieri MV, Garrone O, Galassi B, Ferri C, Berardi R, Ghidini M.
Parisi A, et al. Among authors: maratta mg.
Front Oncol. 2022 Aug 12;12:935826. doi: 10.3389/fonc.2022.935826. eCollection 2022.
Front Oncol. 2022.
PMID: 36033477
Free PMC article.
Item in Clipboard
Primary Tumor Shrinkage and the Effect on Metastatic Disease and Outcomes in Patients With Advanced Kidney Cancer With Intermediate or Poor Prognosis Treated With Nivolumab Plus Ipilimumab or Cabozantinib.
Iacovelli R, Ciccarese C, Maruzzo M, Atzori F, Galli L, Scagliarini S, Massari F, Verzoni E, Cannella A, Maratta MG, Caserta C, Bimbatti D, Deppieri FM, Dessi M, Paolieri F, Riccardi F, Bracarda S, De Giorgi U, Basso U, Tortora G, Procopio G.
Iacovelli R, et al. Among authors: maratta mg.
Clin Genitourin Cancer. 2022 Oct;20(5):498.e1-498.e9. doi: 10.1016/j.clgc.2022.06.006. Epub 2022 Jun 9.
Clin Genitourin Cancer. 2022.
PMID: 35768316
Item in Clipboard
Current evidence for second-line treatment in metastatic renal cell carcinoma after progression to immune-based combinations.
Iacovelli R, Ciccarese C, Procopio G, Astore S, Cannella MA, Maratta MG, Rizzo M, Verzoni E, Porta C, Tortora G.
Iacovelli R, et al. Among authors: maratta mg.
Cancer Treat Rev. 2022 Apr;105:102379. doi: 10.1016/j.ctrv.2022.102379. Epub 2022 Mar 12.
Cancer Treat Rev. 2022.
PMID: 35303548
Review.
Item in Clipboard
The impact of the multidisciplinary tumor board (MDTB) on the management of pancreatic diseases in a tertiary referral center.
Quero G, Salvatore L, Fiorillo C, Bagalà C, Menghi R, Maria B, Cina C, Laterza V, Di Stefano B, Maratta MG, Ribelli M, Galiandro F, Mattiucci GC, Brizi MG, Genco E, D'Aversa F, Zileri L, Attili F, Larghi A, Perri V, Inzani F, Gasbarrini A, Valentini V, Costamagna G, Manfredi R, Tortora G, Alfieri S.
Quero G, et al. Among authors: maratta mg.
ESMO Open. 2021 Feb;6(1):100010. doi: 10.1016/j.esmoop.2020.100010. Epub 2020 Dec 14.
ESMO Open. 2021.
PMID: 33399076
Free PMC article.
Item in Clipboard
Cite
Cite